Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance.
Zhang T, Qu R, Chan S, Lai M, Tong L, Feng F, Chen H, Song T, Song P, Bai G, Liu Y, Wang Y, Li Y, Su Y, Shen Y, Sun Y, Chen Y, Geng M, Ding K, Ding J, Xie H.
Zhang T, et al. Among authors: li y.
Mol Cancer. 2021 Aug 17;20(1):102. doi: 10.1186/s12943-021-01391-x.
Mol Cancer. 2021.
PMID: 34404402
Free PMC article.
No abstract available.